References
- Rosenquist R, Cortese D, Bhoi S, et al. Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?Leuk Lymphoma 2013 Apr 30. [Epub ahead of print]
- Wierda WG, O’Brien S, Wang X, et al. Multivariable model for time to first treatment in patients with chronic lymphocytic leukemia. J Clin Oncol 2011;29:4088–4095.
- Bahlo J, Pflug N, Elter T, et al. Proposal of a prognostic score for previously untreated patients with chronic lymphocytic leukemia based on an overall survival analysis of three German CLL Study Group Phase III trials. Blood 2011;118(Suppl. 1): Abstract 2831.
- Pflug N, Bahlo J, Shanafelt TD, et al. A comprehensive prognostic index for patients with CLL. J Clin Oncol 2013;31(Suppl.): Abstract 7015.
- Molica S, Giannarelli D, Gentile M, et al. External validation on a prospective basis of a nomogram for predicting time to first treatment in patients with chronic lymphocytic leukemia. Cancer 2013;119: 1177–1185.
- Molica S, Giannarelli D, Gentile M, et al. The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysis. Leuk Res 2013;37:943–947.
- Molica S. Survival and disease-progression studies in early chronic lymphocytic leukemia. Blood 1991;78:895–899.
- Rossi D, Rasi S, Spina V, et al. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood 2013;121:1403–1412.